Verrica Pharmaceuticals, Inc. (VRCA)
7.99
-0.25
(-3.03%)
USD |
NASDAQ |
May 08, 16:00
7.95
-0.04
(-0.50%)
After-Hours: 20:00
Verrica Pharmaceuticals EPS Diluted (Quarterly) : -0.5722 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lipocine, Inc. | -0.5404 |
| Cognition Therapeutics, Inc. | -0.0512 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | 0.00 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.074M |
| Revenue (Quarterly) | 5.092M |
| Total Expenses (Quarterly) | 13.17M |
| Enterprise Value | 45.38M |
| Gross Profit Margin (Quarterly) | 72.49% |
| Profit Margin (Quarterly) | -158.6% |
| Earnings Yield | -8.54% |
| Normalized Earnings Yield | -9.289 |